Melanotan-2
Synthetic α-MSH analogue (non-selective melanocortin agonist)
Melanocortin analogue linked to melanogenesis; not approved.
Back to technical sheets- Class
- Synthetic α-MSH analogue (non-selective melanocortin agonist)
- Also known as
- Not approved; illicitly marketed
Mechanism of action
Non-selective melanocortin receptor agonist that stimulates melanogenesis (pigmentation) and has effects on sexual desire.
Evidence
Not approved. Sold illicitly and associated with adverse effects and changes in moles/melanocytes. Preclinical with safety not established.
Studied uses
- None approved
Safety considerations
- Safety concerns (mole changes, melanocytic risk)
- Nausea, flushing, cardiovascular effects
- Unregulated product of uncertain quality
Batch quality data
We publish these figures because they are the ones the program itself teaches you to ask for.
- Purity
- ≥ 98 % (HPLC)
- Net content
- 80 %
- Batch
- MT2-2601
- Presentation
- Polvo liofilizado en vial sellado
Net content is the fraction of the vial’s weight that is actually peptide, after discounting water, salts and excipients. It is the figure to calculate with, not the label weight.
Sample prices and batch data while the real ones are loaded.
Educational reference sheet. It is not a recommendation to use, a clinical indication or a protocol. Many of these compounds are marketed for research use only and are not approved for human use. Always cross-check with the primary literature and the regulation in your country.